Savara Inc.

SVRA XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

1.1B

Short interest (May 15)

13.6%

Net Short (Jun 03 ): 0.1%

Borrow Fee

0.44%

↑ 10.7%

Available Shares

800K

↓ 8.7%

Price Chart

Company Overview

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001160308

Asset Type: CS

Market Data

Market Cap: $1,075,867,863

Employees: 70

Status: Active

Short Interest

Current Borrow Fee 0.44%

Range: 0.40% - 0.44%

Available Shares 800K

Range: 750K - 750K

Recent Changes

Fee Change: ↑ 3.5%

Available Change: ↓ 18.4%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime